Cortrosyn .25 mg/mL (Cosyntropin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) .25 mg/mL

Cortrosyn .25 mg/mL is a lyophilized powder for solution, used for diagnostic purposes in evaluating adrenal function. This cosyntropin injection is manufactured by Amphastar Pharmaceuticals, Inc. in the USA.

Strength

.25 mg/mL

Pack Size

10 VIAL in 1 CARTON (0548-5900-00) / 1 mL in 1 VIAL

Manufacturer / TM Owner

Amphastar Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cortrosyn .25 mg/mL is primarily used to diagnose adrenal insufficiency. It stimulates the adrenal glands to produce cortisol, helping healthcare providers assess adrenal function. This cosyntropin injection is often used in medical settings to determine if the adrenal glands are working properly. What is Cortrosyn used for? It aids in diagnosing conditions related to adrenal gland dysfunction.

Side Effects

When administered, Cortrosyn .25 mg/mL stimulates the adrenal glands to produce cortisol. This can help identify if the adrenal glands are responding adequately to stimulation. Common effects may include temporary increases in cortisol levels, which are monitored by healthcare professionals during diagnostic procedures.

Precautions & Warnings

Cortrosyn .25 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and preparation guidelines to ensure the integrity of the lyophilized powder. Always consult a healthcare provider before use to discuss potential risks and benefits.

Avoid Interactions

Cortrosyn .25 mg/mL may interact with other medications that affect adrenal function or cortisol levels. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effects of this cosyntropin injection.

Frequently Asked Questions

Cortrosyn is used to diagnose adrenal insufficiency by stimulating the adrenal glands to produce cortisol.

Cortrosyn is administered via intramuscular or intravenous injection after reconstitution.

Common effects include temporary increases in cortisol levels, which are monitored during diagnostic procedures.

Cortrosyn should be administered by healthcare professionals in a medical setting.

Follow proper storage and preparation guidelines, and consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.